Equities

ValiRx PLC

VAL:LSE

ValiRx PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)3.05
  • Today's Change0.00 / 0.00%
  • Shares traded1.42m
  • 1 Year change-69.50%
  • Beta0.8352
Data delayed at least 20 minutes, as of May 13 2024 15:37 BST.
More ▼

Financials data is unavailable for this security.

Cash flow in GBPView more

In 2022, ValiRx PLC increased its cash reserves by 91.60%, or 543.81k. Cash Flow from Financing totalled 2.26m or -- of revenues. In addition the company used 1.71m for operations while cash from investing was breakeven.
Cash flow per share-0.0235
Price/Cash flow per share--
Book value per share0.0411
Tangible book value per share0.0174
More ▼

Balance sheet in GBPView more

ValiRx PLC uses little debt in its capital structure as supported by a debt to capital ratio of 0.72%.
Current ratio13.37
Quick ratio--
Total debt/total equity0.0069
Total debt/total capital0.0072
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.